Frequency, duration and severity of salivary effects in DTC patients with onset at 7 weeks to 3 months after I-131 therapy: an analysis of the Thyca National Survey.
Citation: Unpublished 2017/04/01Department: Medicine/Nuclear MedicineForm of publication: Poster PresentationYear: 20172016Conference information: MedStar Health Research Institute: Endocrine Society Annual Meeting (ENDO 2017), Orlando, FL., Fiscal year: FY2017/FY2017/Local accession number: A2017_313Date added to catalog: 2018-08-01| Item type | Current library | Collection | Call number | Status | Date due | Barcode |
|---|---|---|---|---|---|---|
| Poster Presentation | MedStar Authors Catalog | Poster | Available |